An unusual complication of a long-acting injectable antipsychotic: deep venous thrombosis caused by olanzapine pamoate

Antipsychotic drugs are widely used in psychiatry and are associated with an increased risk of adverse effects such as venous thromboembolism. Olanzapine pamoate is a long-acting injectable form of the second-generation antipsychotic agent. It is used especially in schizophrenia patients who are non...

Full description

Bibliographic Details
Published in:	Psychiatry and Clinical Psychopharmacology
Main Authors:	Serhat Tunç, Hamit Serdar Başbuğ
Format:	Article
Language:	English
Published:	Mesut Çetin 2018-04-01
Subjects:	Long-acting antipsychotics deep venous thrombosis olanzapine pamoate
Online Access:	http://dx.doi.org/10.1080/24750573.2017.1406036

Similar Items

Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
by: Detke Holland C, et al.
Published: (2012-05-01)

Postinjection delirium/sedation syndrome with olanzapine depot injection
by: Sadhvi Mythili Sarangula, et al.
Published: (2016-01-01)

Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series
by: Jiri Masopust, et al.
Published: (2019-05-01)

Central retinal vein occlusion in a patient using the antipsychotic drug olanzapine: a case report
by: Ali Nowrouzi, et al.
Published: (2021-05-01)

Tunable Intranasal Polymersome Nanocarriers Triggered Olanzapine Brain Delivery and Improved In Vivo Antipsychotic Activity
by: Ahmed A. Katamesh, et al.
Published: (2025-06-01)

Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Is there association of olanzapine and pulmonary embolism: A case report
by: Lumin Wang, et al.
Published: (2022-06-01)

Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
by: Tomohiko Kimura, et al.
Published: (2024-03-01)

Olanzapine-associated hypothermia: a case report of a rare event
by: Manuel Monti, et al.
Published: (2018-02-01)

Olanzapine-induced bilateral pedal and pretibial edema: A case report
by: Behice Han Almis, et al.
Published: (2019-06-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Assessment of lipid response to acute olanzapine administration in healthy adults
by: Avital Nahmias, et al.
Published: (2020-04-01)

Olanzapine as a Cause of Urinary Incontinence: A Case Report
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Olanzapine as a cause of urinary incontinence: a case report.
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)

Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit
by: Sarah Gamcsik, PharmD, et al.
Published: (2024-08-01)

Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
by: Emma L. Gunderson, et al.
Published: (2022-02-01)

Olanzapine induced biochemical and histopathological changes after its chronic administration in rats
by: Rehmat Shah, et al.
Published: (2016-11-01)

Olanzapine-induced skin rash: A case report
by: Mansi Shah, et al.
Published: (2019-01-01)

The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment
by: JiaHui Zeng, et al.
Published: (2025-01-01)

The Risk of Venous Thromboembolism Events Resulting in Hospitalization following Exposure to Antipsychotic Medication in Pre-Disposed Adult Patients
by: Rachel Kahle, et al.
Published: (2024-06-01)

Pancreatitis following Olanzapine Therapy: A Report of Three Cases
by: Thomas A. Kerr, et al.
Published: (2007-06-01)

A CLINICAL STUDY OF THE USE OF PYRVINIUM PAMOATE WITH PIPERAZINE (VANPAR®) IN THE TREATMENT OF OXYURIASIS AND ASCARIASIS
by: M.A. Barzgar, et al.
Published: (1974-07-01)

Effect of metformin on olanzapine-induced weight gain: A 12-week randomised open-label study
by: G. Chetan Kumar, et al.
Published: (2025-01-01)

Antipsychotic drugs as a contributing factor of pulmonary embolism: A report of 4 cases
by: Mosaab Maazouzi, MD, et al.
Published: (2023-05-01)

Negative Impact of Olanzapine on ICU Delirium Resolution: An Emulated Clinical Trial
by: Ajna Hamidovic, et al.
Published: (2025-07-01)

A Review of Vesicular and Polymeric Nano-systems in Olanzapine Drug Delivery
by: Javad Setareh, et al.
Published: (2022-01-01)

The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature
by: G. Saudemont, et al.
Published: (2020-04-01)

Comparative evaluation of pancreatic histopathology of rats treated with olanzapine, risperidone and streptozocin
by: Rehmat Shah, et al.
Published: (2018-11-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
by: Hong Jihyung, et al.
Published: (2012-12-01)

In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against <i>Leishmania</i>
by: Estela Melcón-Fernández, et al.
Published: (2024-01-01)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-05-01)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-06-01)

Development of acute pancreatitis after oral administering a praziquantel, pyrantel pamoate, and febantel combination in a dog: A case report
by: Masashi Yuki, et al.
Published: (2023-06-01)

In vivo efficacy of pyrantel pamoate as a post-exposure prophylactic for rat lungworm (Angiostrongylus cantonensis)
by: John Jacob, et al.
Published: (2022-08-01)

Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
by: Yali Li, et al.
Published: (2022-12-01)

Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being
by: Anand E, et al.
Published: (2016-10-01)

One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
by: Mohammed Zain Ulabedin Adhoni, et al.
Published: (2021-10-01)

Typical and Atypical Antipsychotic Drugs Increase Extracellular Histamine Levels in the Rat Medial Prefrontal Cortex: Contribution of Histamine H1 Receptor Blockade
by: Kjell A Svensson
Published: (2012-05-01)